showed that sEVs-mediated TGF-β1/Smad pathway further promoted BC cells proliferation and migration by inhibiting apoptosis and enhancing epithelial mesenchymal transition (EMT), which in turn contributes to adriamycin resistance in BC cells (65). Here, TGFB1 is linked to breast cancer.